🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Rapid response team activation prior to in-hospital cardiac arrest: Areas for improvements based on a national cohort study - Resuscitation resuscitationjournal.com/article/S0300-… K

Happy to announce #PHRI Senior Scientist Jeff Healey will present on the results of #ARTESIAtrial, the 15-year global #RCT on device-detected #atrialfibrillation, at #AHA23 on Nov. 12, 8:45 am ET. eppro01.ativ.me/src/EventPilot… AHA Science American Heart Association #Latebreakingtrial

Oral Anticoagulation in ICH Patients With AF: New Data medscape.com/viewarticle/99… via Medscape

afspice.com Passing 900 randomized patients in AF SPICE, on a path towards less knowledge gaps in ECG screening post stroke.

With @ARTESIA_RCT presented at #AHA23 this AM, many are working to reconcile the positive results with those from NOAH AFNET 6 from #ESC2023. This meta-analysis does just that. The trials are totally consistent: ahajournals.org/doi/10.1161/CI… #EPeeps

Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation | NEJM Amazing results from Artesia. nejm.org/doi/full/10.10…

What Lies beneath the Surface — Treatment of Subclinical Atrial Fibrillation | NEJM www-nejm-org.proxy.kib.ki.se/doi/full/10.10… You have to read the Artesia editorial by Emma Svennberg !

Amazing PhD defense from Anna Thorén at Danderyds Hospital today, with her Thesis on Prediction and Monitoring of in-hospital cardiac arrest. Many congrats!

BREAKING OCEANIC-AF study stopped early due to lack of efficacy Independent Data Monitoring Committee (IDMC) recommends stopping the OCEANIC-AF study due to inferior efficacy of #asundexian vs apixaban in atrial fibrillation bayer.com/media/en-us/oc…

Finally, we publish the study design of the secondary preventive AF screening study AF SPICE! Study commenced inclusion in january 2022. Nice to hear any comments from you. bmjopen.bmj.com/content/13/11/…

Randomised, siteless study to compare systematic atrial fibrillation screening using enrichment by a risk prediction model with standard care in a Swedish population aged ≥ 65 years: CONSIDERING-AF study design BMJ_Open bmjopen.bmj.com/content/14/1/e…

ISC 2024: Data from STROKE AF study show cost effectiveness of ICM in ischaemic stroke patients cardiacrhythmnews.com/stroke-af-cost… I believe this cost effectiveness analysis would have been strengthened with outcomes.

ahajournals.org/doi/10.1161/CI… Very well formulated editorial by Lars Wallentin and Robert Giugliano on the FRAIL AF study!

For you interested in AFib and rhythm-versus-rate control: Hold the date of the public scientific defense of dr. Marita K. Pope, our MD-PhD-candidate. April 22nd, 2024. Trial Lecture at 10:15 and defense at 13:15. ‘Gamle Festsal’ of the University of Oslo, next to the Aula.

Sid M. Patel Circulation Thank you for your balanced and insightful editorial.

The STROKESTOP publication pedigree, with a few more to come. Happy Easter!

Presented at #ACC24: Hospitalized patients with acute myocardial infarction & preserved EF were assigned to receive open-label long-term beta-blocker therapy or not. Beta-blockers did not lead to a lower risk of death or MI. Full REDUCE-AMI trial results: nej.md/4akVhRx

Validation of a novel smartphone-based photoplethysmographic method for ambulatory heart rhythm diagnostics academic.oup.com/europace/artic… Heart rhythm recording using smartphone photopletysmography (PPG) has an enormous potential given the device availability.

Happy to invite all interested in the future of heart rhythm monitoring to Dr Jonatan Fernstads presentation on large-scale data of machine learning reading of smartphone PPG, ESC congress Saturday 31st at Science Box 2 - Research Gateway. lnkd.in/dsRDpdex #ESCCongress

We are proudly looking forward to the presentation of the STROKESTOP 2 study by Katrin Kemp Gudmundsdottir on sunday september 1st, #ESCCongress hotline 9. Many thanks to the 6868 participants from the Stockholm region and Roche Diagnostics for inspiring collaboration.